Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Immune reconstitution inflammatory syndrome in a HIV-infected patient with disseminated tuberculosis.

Koh KC, Pak JW.

Malays Fam Physician. 2016 Apr 30;11(1):27-30. eCollection 2016.

2.

TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.

Bell L, Peyper JM, Garnett S, Tadokera R, Wilkinson R, Meintjes G, Blackburn JM.

Exp Mol Pathol. 2017 Apr;102(2):237-246. doi: 10.1016/j.yexmp.2017.02.008. Epub 2017 Feb 14.

3.

Neurotuberculosis immune reconstitution inflammatory syndrome in the setting of HIV infection: A case report and review of literature.

Jaganmohan D, Chakkalakkoombil SV, Beena AA, Krishnan N.

Indian J Radiol Imaging. 2016 Oct-Dec;26(4):446-450. doi: 10.4103/0971-3026.195782.

4.

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).

Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, Ravinetto R, Wouters E, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, Meintjes G.

JMIR Res Protoc. 2016 Aug 29;5(3):e173. doi: 10.2196/resprot.6046.

5.

Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.

Dirix V, Schepers K, Massinga-Loembe M, Worodria W, Colebunders R, Singh M, Locht C, Kestens L, Mascart F; TB-IRIS study group.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):344-52. doi: 10.1097/QAI.0000000000000980.

6.

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.

Lai RP, Meintjes G, Wilkinson RJ.

Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2. Epub 2015 Sep 30. Review.

7.

Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge.

Bisson GP, Zetola N, Collman RG.

Curr HIV/AIDS Rep. 2015 Mar;12(1):107-16. doi: 10.1007/s11904-015-0256-x. Review.

8.

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G; COAT Trial Team.

N Engl J Med. 2014 Jun 26;370(26):2487-98. doi: 10.1056/NEJMoa1312884.

9.
10.

Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection.

Patel MR, Nana M, Yotebieng M, Tabala M, Behets F, Van Rie A.

Int J Tuberc Lung Dis. 2014 Jun;18(6):694-9. doi: 10.5588/ijtld.13.0807.

11.

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.

Yang CH, Chen KJ, Tsai JJ, Lin YH, Cheng SH, Wang KF, Chiou HY.

BMC Infect Dis. 2014 Jun 4;14:304. doi: 10.1186/1471-2334-14-304.

12.

Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.

Link-Gelles R, Moultrie H, Sawry S, Murdoch D, Van Rie A.

Pediatr Infect Dis J. 2014 May;33(5):499-503. doi: 10.1097/INF.0000000000000142. Review.

13.

Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.

Bonnet M, Baudin E, Jani IV, Nunes E, Verhoustraten F, Calmy A, Bastos R, Bhatt NB, Michon C.

PLoS One. 2013 Dec 18;8(12):e84585. doi: 10.1371/journal.pone.0084585. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/15d01128-2495-4b95-8fe8-8702190fdb0e.

14.

Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays.

Kerkhoff AD, Wood R, Vogt M, Lawn SD.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):33-40. doi: 10.1097/QAI.0000000000000091.

15.

Bullous disorders as a manifestation of immune reconstitution inflammatory syndrome: A series of three cases.

Das R, Sarkar S, Besra M.

Indian J Sex Transm Dis. 2013 Jul;34(2):126-8. doi: 10.4103/0253-7184.120552.

16.

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.

Lawn SD, Meintjes G, McIlleron H, Harries AD, Wood R.

BMC Med. 2013 Dec 2;11:253. doi: 10.1186/1741-7015-11-253. Review.

17.

Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.

Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J; Adult AIDS Clinical Trials Group A5221 Study Team.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):423-8. doi: 10.1097/QAI.0000000000000030.

18.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).

Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K, Haas B, Hahn K, Härter G, Hartmann M, Herzmann C, Hutterer J, Jordan AR, Lange C, Mauss S, Meyer-Olson D, Mosthaf F, Oette M, Reuter S, Rieger A, Rosenkranz T, Ruhnke M, Schaaf B, Schwarze S, Stellbrink HJ, Stocker H, Stoehr A, Stoll M, Träder C, Vogel M, Wagner D, Wyen C, Hoffmann C; Deutsche AIDS Gesellschaft; Österreichische AIDS-Gesellschaft.

Infection. 2013 Sep;41 Suppl 2:S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14.

19.

Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population.

Yang CH, Chan PC, Liao ST, Cheng SH, Wong WW, Huang LM, Hsueh PR, Chiou HY.

PLoS One. 2013 Aug 27;8(8):e73069. doi: 10.1371/journal.pone.0073069. eCollection 2013.

20.

Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, Bisson GP.

J Infect Dis. 2013 Dec 1;208(11):1784-93. doi: 10.1093/infdis/jit368. Epub 2013 Aug 1.

Supplemental Content

Support Center